Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pelentan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
In rats with secondary avitaminosis-K induced by Pelentan the collagen content in the skin is reduced and the content of free… Expand
1997
1997
A randomized study was carried out of the efficacy of a new procedure of adjuvant immunotherapy for cancer of corpus uteri in… Expand
1992
1992
A 49-year-old man contracted a fracture of the 8th and 9th rib on the right side and developed after this injury thrombosis of… Expand
1992
1992
Vitamin K (vikasol) and pelentan were examined for their effects of periodontal tissue levels of collagen, hexosamine-containing… Expand
1984
1984
This study describes the effect of a chronic decrease in hematocrit on blood pressure, cardiac output (CO), total peripheral… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
1976
1976
Secondary vitamin K deficiency in rats caused by pelentan was accompanied by a decrease in the total collagen content and a rise… Expand
1953
1953
TROMEXAN (ethyl biscoumacetate; 3, 3′ carboxymethylenebis- [4-hydroxycoumarin] ethyl ester also known as B.O.E.A., D.E.A. and… Expand
1952
1952
1951
1951
The common use of dicumarinyl derivatives for the treatment of thromboembolic diseases justifies further clinical evaluation of… Expand
  • figure 1
  • table 1
  • figure 5
  • table 3
  • table 2
1951
1951
  • R. P. Gripe
  • The New England journal of medicine
  • 1951
  • Corpus ID: 23493387
TROMEXAN, a new anticoagulant, has recently been accepted for general use. Chemically, it is described as ethyl biscoumacetate (3… Expand